Health Trials

Inoperable Disease

2

Review clinical trials related to Inoperable Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

The purpose of this study is to find out if the administration of Interleukin-2 concurrently with ipilimumab followed by Nivolumab will result in improved anti-cancer activity and if it is effective for advanced melanoma.

Participants needed: 29
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: H. Lee Moffitt Cancer Center and Research InstituteUpdated: Apr 1, 2026Locations: 1
Eligibility criteria

Histologically or cytologically confirmed metastatic melanoma. This includes Ame... [+18]

Patients who have had systemic therapy for melanoma or radiotherapy within 3 wee... [+6]

Read more
Status: Recruiting

Checkpoint Inhibitor Combinations Therapy as First Line for Inoperable Lung Cancer Via IT

This trial is designed to investigate the safety, response rates and survival outcomes of patients with inoperable lung cancer by infusion of CTLA4, PD1 and PDL1 antibodies combination with chemodrug or/and bevacizumab through intra-tumor (IT).

Participants needed: 90
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Second Affiliated Hospital of Guangzhou Medical UniversityUpdated: Jul 3, 2024Locations: 1
Eligibility criteria

Cytohistological confirmation is required for diagnosis of cancer. [+8]

Patients participated in clinical trials of equipment or drugs (signed informed... [+8]

Read more